Dependence On ADC Drugs Will Erode Margins But Spur Recovery
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 16 Analysts
Published
13 Jul 25
Updated
20 Aug 25
AnalystLowTarget's Fair Value
JP¥4,500.00
17.8% undervalued intrinsic discount20 Aug
JP¥3,700.00
1Y
-37.9%7D
0.7%